FEDERALUnknownLow
Drugs Made In America Acquisition Corp.
bd_628875532b2b4649 · schema v1 · pii pii-v1
Full breach record for Drugs Made In America Acquisition Corp. →Special purpose acquisition company (SPAC) Item 1C disclosure stating it has no business operations beyond identifying acquisition candidates, does not face significant cybersecurity risk, has not adopted a formal cybersecurity risk management program, and has not encountered any cybersecurity incidents since its IPO. Board of directors holds general oversight responsibility.
Tracked as a single-filing incident — the only disclosure on record for this event so far.ConfirmedView incident
Source provenance
- Source URL
- https://www.sec.gov/Archives/edgar/data/2028614/000121390026044139/ea0285662-10k_drugs.htm
DisclosureLens renders the full SEC/HHS filing inline below from the originating regulator’s public record (§4.5 fair report privilege).
- Filed at
- Apr 15, 2026
- Raw hash
- dedd86fc9d5d6588f69344eaebd53b266feb4b702a288f1f77580bed8bf623fa
Source filing
AI-assisted summary above. The structured extract on this page was generated from the document below. Inspect the source to verify or correct any field.
Reporting entity
- Name
- Drugs Made In America Acquisition Corp.norm: drugs made in america acquisition
- SEC CIK
- 0002028614
Victim entity
- Name
- Drugs Made In America Acquisition Corp.norm: drugs made in america acquisition
Incident
- Discovered
- —
- Materiality determined
- —
- Notification sent
- —
- Affected individuals
- Not disclosed
- Data types
- —
- Attack vector
- Unknown
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.